Hitesh S Purohit1, James D Ormes2, Sugandha Saboo1, Yongchao Su3, Matthew S Lamm2, Amanda K P Mann4, Lynne S Taylor5. 1. Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University,, West Lafayette, Indiana, 47907, USA. 2. Preformulation, MRL,, Merck & Co., Inc., Rahway, New Jersey, 07065, USA. 3. Preformulation, MRL,, Merck & Co., Inc., West Point, Pennsylvania, 19486, USA. 4. Analytical Sciences, MRL,, Merck & Co., Inc., Rahway, New Jersey, 07065, USA. 5. Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University,, West Lafayette, Indiana, 47907, USA. lstaylor@purdue.edu.
Abstract
PURPOSE: Miscibility between the drug and the polymer in an amorphous solid dispersion (ASD) is considered to be one of the most important factors impacting the solid state stability and dissolution performance of the active pharmaceutical ingredient (API). The research described herein utilizes emerging fluorescence-based methodologies to probe (im)miscibility of itraconazole (ITZ)-hydroxypropyl methylcellulose (HPMC) ASDs. METHODS: The ASDs were prepared by solvent evaporation with varying evaporation rates and were characterized by steady-state fluorescence spectroscopy, confocal imaging, differential scanning calorimetry (DSC), and solid state nuclear magnetic resonance (ssNMR) spectroscopy. RESULTS: The size of the phase separated domains for the ITZ-HPMC ASDs was affected by the solvent evaporation rate. Smaller domains (<10 nm) were observed in spray-dried ASDs, whereas larger domains (>30 nm) were found in ASDs prepared using slower evaporation rates. Confocal imaging provided visual confirmation of phase separation along with chemical specificity, achieved by selectively staining drug-rich and polymer-rich phases. ssNMR confirmed the results of fluorescence-based techniques and provided information on the size of phase separated domains. CONCLUSIONS: The fluorescence-based methodologies proved to be sensitive and rapid in detecting phase separation, even at the nanoscale, in the ITZ-HPMC ASDs. Fluorescence-based methods thus show promise for miscibility evaluation of spray-dried ASDs.
PURPOSE: Miscibility between the drug and the polymer in an amorphous solid dispersion (ASD) is considered to be one of the most important factors impacting the solid state stability and dissolution performance of the active pharmaceutical ingredient (API). The research described herein utilizes emerging fluorescence-based methodologies to probe (im)miscibility of itraconazole (ITZ)-hydroxypropyl methylcellulose (HPMC) ASDs. METHODS: The ASDs were prepared by solvent evaporation with varying evaporation rates and were characterized by steady-state fluorescence spectroscopy, confocal imaging, differential scanning calorimetry (DSC), and solid state nuclear magnetic resonance (ssNMR) spectroscopy. RESULTS: The size of the phase separated domains for the ITZ-HPMC ASDs was affected by the solvent evaporation rate. Smaller domains (<10 nm) were observed in spray-dried ASDs, whereas larger domains (>30 nm) were found in ASDs prepared using slower evaporation rates. Confocal imaging provided visual confirmation of phase separation along with chemical specificity, achieved by selectively staining drug-rich and polymer-rich phases. ssNMR confirmed the results of fluorescence-based techniques and provided information on the size of phase separated domains. CONCLUSIONS: The fluorescence-based methodologies proved to be sensitive and rapid in detecting phase separation, even at the nanoscale, in the ITZ-HPMC ASDs. Fluorescence-based methods thus show promise for miscibility evaluation of spray-dried ASDs.
Entities:
Keywords:
amorphous solid dispersion; fluorescence; miscibility; solid state nuclear magnetic resonance
Authors: Karel Six; Hugo Berghmans; Christian Leuner; Jennifer Dressman; Kristof Van Werde; Jules Mullens; Luc Benoist; Mireille Thimon; Laurent Meublat; Geert Verreck; Jef Peeters; Marcus Brewster; Guy Van den Mooter Journal: Pharm Res Date: 2003-07 Impact factor: 4.200
Authors: Geert Verreck; Karel Six; Guy Van den Mooter; Lieven Baert; Jef Peeters; Marcus E Brewster Journal: Int J Pharm Date: 2003-01-30 Impact factor: 5.875
Authors: Clara E Correa Soto; Yi Gao; Anura S Indulkar; Keisuke Ueda; Geoff G Z Zhang; Lynne S Taylor Journal: Pharm Res Date: 2022-01-10 Impact factor: 4.200
Authors: Na Li; Jonathan L Cape; Bharat R Mankani; Dmitry Y Zemlyanov; Kimberly B Shepard; Michael M Morgen; Lynne S Taylor Journal: Mol Pharm Date: 2020-09-24 Impact factor: 4.939